Cargando…
Hafnia alvei HA4597 Strain Reduces Food Intake and Body Weight Gain and Improves Body Composition, Glucose, and Lipid Metabolism in a Mouse Model of Hyperphagic Obesity
Use of new generation probiotics may become an integral part of the prevention and treatment strategies of obesity. The aim of the present study was to test the efficacy of a potential probiotic strain of lactic bacteria Hafnia alvei (H. alvei) HA4597™, in a mouse model of obesity characterized by b...
Autores principales: | Lucas, Nicolas, Legrand, Romain, Deroissart, Camille, Dominique, Manon, Azhar, Saïda, Le Solliec, Marie-Anne, Léon, Fatima, do Rego, Jean-Claude, Déchelotte, Pierre, Fetissov, Sergueï O., Lambert, Grégory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023249/ https://www.ncbi.nlm.nih.gov/pubmed/31878078 http://dx.doi.org/10.3390/microorganisms8010035 |
Ejemplares similares
-
Commensal Hafnia alvei strain reduces food intake and fat mass in obese mice—a new potential probiotic for appetite and body weight management
por: Legrand, Romain, et al.
Publicado: (2020) -
The Probiotic Strain H. alvei HA4597(®) Improves Weight Loss in Overweight Subjects under Moderate Hypocaloric Diet: A Proof-of-Concept, Multicenter Randomized, Double-Blind Placebo-Controlled Study
por: Déchelotte, Pierre, et al.
Publicado: (2021) -
The impact of Hafnia alvei HA4597™ on weight loss and glycaemic control after bariatric surgery — study protocol for a triple-blinded, blocked randomized, 12-month, parallel-group, placebo-controlled clinical trial
por: Ismael, Shámila, et al.
Publicado: (2023) -
Catheter-associated Hafnia alvei-induced Urosepsis
por: Yarlagadda, Keerthi, et al.
Publicado: (2019) -
Hafnia alvei Urosepsis in a Kidney Transplant Patient
por: Stanic, Mario, et al.
Publicado: (2015)